Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R5AA
|
||||
Drug Name |
Xmab5871
|
||||
Drug Type |
Monoclonal antibody
|
||||
Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Phase 1/2 | [889425] | ||
Company |
Xencor
|
||||
Target and Pathway | |||||
Target(s) | CD32b | Target Info | Modulator | [889442] | |
B-lymphocyte antigen CD19 | Target Info | Modulator | [889442] | ||
NetPath Pathway | Leptin Signaling PathwayNetPath_19:IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | ||||
BCR signaling pathwaybcr_5pathway:BCR signaling pathway | |||||
Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cellR-HSA-1257604:PIP3 activates AKT signaling | ||||
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | |||||
Constitutive Signaling by Aberrant PI3K in Cancer | |||||
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.